Cargando…
Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients
We investigated whether the additional determination of ceruloplasmin (Cp) levels could improve the prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in heart failure (HF) patients in a 1-year follow-up. Cp and NT-proBNP levels and clinical and laboratory parameters were asse...
Autores principales: | Romuk, Ewa, Jacheć, Wojciech, Zbrojkiewicz, Ewa, Mroczek, Alina, Niedziela, Jacek, Gąsior, Mariusz, Rozentryt, Piotr, Wojciechowska, Celina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019681/ https://www.ncbi.nlm.nih.gov/pubmed/31947878 http://dx.doi.org/10.3390/jcm9010137 |
Ejemplares similares
-
Ceruloplasmin as Redox Marker Related to Heart Failure Severity
por: Lazar-Poloczek, Elżbieta, et al.
Publicado: (2021) -
Comparison of Oxidative Stress Parameters in Heart Failure Patients Depending on Ischaemic or Nonischaemic Aetiology
por: Romuk, Ewa, et al.
Publicado: (2019) -
Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy
por: Wojciechowska, Celina, et al.
Publicado: (2021) -
Malondialdehyde and Uric Acid as Predictors of Adverse Outcome in Patients with Chronic Heart Failure
por: Romuk, Ewa, et al.
Publicado: (2019) -
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)